View Older Stories View More Recent Stories

Nov 8, 2019 05:26PM Form SC 13G Phathom Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.

Nov 4, 2019 08:30AM X4 Pharmaceuticals Appoints Derek Meisner, J.D., as General Counsel

Oct 22, 2019 08:38AM PlacementTracker Publishes Q3 2019 PIPE and Private Placement Markets League Tables

Oct 18, 2019 05:04PM Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC

Oct 11, 2019 04:12PM Form SC 13D/A Ra Pharmaceuticals, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Oct 10, 2019 09:05AM Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent

Oct 1, 2019 08:00AM Vor Biopharma Hires Senior Cell and Gene Therapy Leaders as Chief Technology Officer and Vice President of Research

Sep 23, 2019 09:00AM Nkarta Therapeutics Named as a “Fierce 15” Biotechnology Company of 2019

Sep 23, 2019 09:00AM FierceBiotech names Frontier Medicines one of its "Fierce 15" biotech companies of 2019

Sep 18, 2019 08:00AM Nkarta Therapeutics Promotes Nadir Mahmood, Ph.D., to Chief Business Officer

Sep 17, 2019 04:54PM Form SC 13D Satsuma Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC

Sep 10, 2019 08:00AM Nkarta Therapeutics Appoints Vice President of Regulatory Affairs

Sep 4, 2019 08:00AM Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials

Sep 3, 2019 07:00AM Achilles Therapeutics raises £100 million in oversubscribed Series B financing

Sep 3, 2019 02:00AM Achilles Therapeutics raises £100 million in oversubscribed Series B financing

Aug 27, 2019 09:21AM ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million

Aug 23, 2019 10:47AM ESSA Pharma Inc. (EPIX) Anounces Proposed $36M Share Offering and Concurrent Private Placement

Aug 23, 2019 10:37AM ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement

Aug 14, 2019 04:32PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30

Aug 14, 2019 07:30AM Solid Biosciences (SLDB) Tops Q2 EPS by 3c

Aug 14, 2019 07:25AM Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update

Aug 7, 2019 08:30AM Vor Biopharma Appoints Veteran Biotech Executive Dr. Robert Ang as President and Chief Executive Officer

Jul 31, 2019 09:05AM Frontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies

Jul 31, 2019 08:30AM Vor Biopharma Appoints Dr. Bill Lundberg to Its Board of Directors

Jul 30, 2019 05:20PM Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Jul 26, 2019 07:27AM Solid Biosciences (SLDB) Announces $60 Million Private Placement of Common Stock and Warrants

Jul 26, 2019 07:25AM Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors

Jul 24, 2019 09:00AM Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection

Jul 15, 2019 09:00AM RA Capital Management Closes First Venture Fund

Jul 10, 2019 04:32PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC

Jun 25, 2019 09:00AM Frontier Medicines launches with $67 million to develop novel medicines that drug the "undruggable" targets driving human disease

Jun 4, 2019 07:00AM Phathom Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference

May 15, 2019 04:51PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31

May 7, 2019 08:00AM Science2Startup Symposium Convened Close to 300 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections to Advance Scientific Innovation and Entre

May 2, 2019 09:03AM Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe M

Apr 24, 2019 04:43PM Form SC 13D/A KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 24, 2019 09:00AM Satsuma Pharmaceuticals Raises $62 Million in Series B Preferred Stock Financing

Apr 23, 2019 09:03AM Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal

Apr 15, 2019 04:36PM Form SC 13D/A KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 12, 2019 07:00AM Atlas Venture, F-Prime Capital, RA Capital Management, and Osage University Partners to Host Second Annual Science2Startup Symposium

Apr 10, 2019 05:22PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 10, 2019 07:30AM Inozyme Pharma Raises $67 Million in Series A2 Financing to Develop Therapies for Rare Mineralization Disorders

Mar 27, 2019 04:00PM Prevail Therapeutics Secures $50 Million in Series B Financing to Advance Pipeline of Gene Therapies for Neurodegenerative Diseases

Mar 26, 2019 07:00AM Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Mar 26, 2019 07:00AM Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Mar 14, 2019 09:03AM Ivantis Announces 24-Month Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial

Mar 7, 2019 08:00AM Stoke Therapeutics to Present on First Disease-Modifying Therapies for Genetic Epilepsies at Cowen and Company Annual Health Care Conference

Feb 26, 2019 07:30AM Behind the Seizure™ Program Expansion Helps Speed the Diagnosis of Genetic Epilepsy in Younger Children Experiencing Unprovoked Seizures

Feb 20, 2019 08:00AM Peloton Therapeutics Secures $150 Million in Series E Financing

Feb 14, 2019 05:16PM Form SC 13G RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC

View More Recent Stories View Older Stories